146 related articles for article (PubMed ID: 31268978)
1. Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis.
Nadella S; Burks J; Huber M; Wang J; Cao H; Kallakury B; Tucker RD; Boca SM; Jermusyck A; Collins I; Vietsch EE; Pierobon M; Hodge KA; Cui W; Amundadottir LT; Petricoin E; Shivapurkar N; Smith JP
Pancreas; 2019 Aug; 48(7):894-903. PubMed ID: 31268978
[TBL] [Abstract][Full Text] [Related]
2. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice.
Philip B; Roland CL; Daniluk J; Liu Y; Chatterjee D; Gomez SB; Ji B; Huang H; Wang H; Fleming JB; Logsdon CD; Cruz-Monserrate Z
Gastroenterology; 2013 Dec; 145(6):1449-58. PubMed ID: 23958541
[TBL] [Abstract][Full Text] [Related]
3. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Keenan BP; Saenger Y; Kafrouni MI; Leubner A; Lauer P; Maitra A; Rucki AA; Gunderson AJ; Coussens LM; Brockstedt DG; Dubensky TW; Hassan R; Armstrong TD; Jaffee EM
Gastroenterology; 2014 Jun; 146(7):1784-94.e6. PubMed ID: 24607504
[TBL] [Abstract][Full Text] [Related]
4. Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D
DelGiorno KE; Chung CY; Vavinskaya V; Maurer HC; Novak SW; Lytle NK; Ma Z; Giraddi RR; Wang D; Fang L; Naeem RF; Andrade LR; Ali WH; Tseng H; Tsui C; Gubbala VB; Ridinger-Saison M; Ohmoto M; Erikson GA; O'Connor C; Shokhirev MN; Hah N; Urade Y; Matsumoto I; Kaech SM; Singh PK; Manor U; Olive KP; Wahl GM
Gastroenterology; 2020 Nov; 159(5):1866-1881.e8. PubMed ID: 32717220
[TBL] [Abstract][Full Text] [Related]
5. Target-Specific Nanoparticle Polyplex Down-Regulates Mutant
Smith JP; Chen W; Shivapurkar N; Gerber M; Tucker RD; Kallakury B; Dasa SSK; Kularatne RN; Stern ST
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614194
[TBL] [Abstract][Full Text] [Related]
6. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.
Bai H; Li H; Zhang W; Matkowskyj KA; Liao J; Srivastava SK; Yang GY
Carcinogenesis; 2011 Nov; 32(11):1689-96. PubMed ID: 21859833
[TBL] [Abstract][Full Text] [Related]
8. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV
Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056
[TBL] [Abstract][Full Text] [Related]
9. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
Garcia MN; Grasso D; Lopez-Millan MB; Hamidi T; Loncle C; Tomasini R; Lomberk G; Porteu F; Urrutia R; Iovanna JL
J Clin Invest; 2014 Nov; 124(11):4709-22. PubMed ID: 25250570
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model.
Smith JP; Cao H; Chen W; Kallakury B; Phillips T; Sutton L; Cato A
Cancer Prev Res (Phila); 2021 Oct; 14(10):933-944. PubMed ID: 34429319
[TBL] [Abstract][Full Text] [Related]
11. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Lee JC; Shin J; Baek KH
Biochem Biophys Res Commun; 2013 Oct; 440(1):50-5. PubMed ID: 24041692
[TBL] [Abstract][Full Text] [Related]
12. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
13. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
[TBL] [Abstract][Full Text] [Related]
14. Proteasome activity is required for the initiation of precancerous pancreatic lesions.
Furuyama T; Tanaka S; Shimada S; Akiyama Y; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Fukamachi H; Arii S; Kawaguchi Y; Tanabe M
Sci Rep; 2016 May; 6():27044. PubMed ID: 27244456
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
[TBL] [Abstract][Full Text] [Related]
17. ARID1A suppresses malignant transformation of human pancreatic cells via mediating senescence-associated miR-503/CDKN2A regulatory axis.
Li ZY; Zhu SS; Chen XJ; Zhu J; Chen Q; Zhang YQ; Zhang CL; Guo TT; Zhang LM
Biochem Biophys Res Commun; 2017 Nov; 493(2):1018-1025. PubMed ID: 28942143
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.
Kato H; Tateishi K; Fujiwara H; Ijichi H; Yamamoto K; Nakatsuka T; Kakiuchi M; Sano M; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Otsuka M; Hirata Y; Tachibana M; Shinkai Y; Koike K
Cancer Genomics Proteomics; 2020; 17(6):695-705. PubMed ID: 33099471
[TBL] [Abstract][Full Text] [Related]
19. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.
Murphy SJ; Hart SN; Lima JF; Kipp BR; Klebig M; Winters JL; Szabo C; Zhang L; Eckloff BW; Petersen GM; Scherer SE; Gibbs RA; McWilliams RR; Vasmatzis G; Couch FJ
Gastroenterology; 2013 Nov; 145(5):1098-1109.e1. PubMed ID: 23912084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
